GoHealth director Tawil resigns; Christopher Litchford appointed as Centerbridge designee

GoHealth, Inc.

Tawil resigned as Centerbridge director on Sept 11, 2022; no disagreement with GoHealth.
Christopher Litchford, Managing Director at Centerbridge, appointed to Board on Sept 14, 2022.
Litchford will serve as Class II director with term expiring at the 2025 annual meeting.
Litchford receives no additional compensation for board service; standard indemnification executed.
No reportable related-party transactions between Litchford and GoHealth beyond Centerbridge matters.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher Litchford

Director

GOCO · GoHealth, Inc.

Effective: 2022-09-14
Filed: September 15, 2022, 7:59 PM ET

Mr. Litchford was appointed as a director by the Board of the Company on September 14, 2022

Departed

Ms. Tawil

Director

GOCO · GoHealth, Inc.

Effective: 2022-09-11
Successor: Christopher Litchford
Filed: September 15, 2022, 7:59 PM ET

On September 11, 2022, Ms. Tawil resigned from the Board of the Company as a Centerbridge Director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Litchford was appointed as Director at GoHealth, Inc..

Action: appointed
Role: Director

Exact text from the filing

Mr. Litchford was appointed as a director by the Board of the Company on September 14, 2022

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ms. Tawil resigned as Director at GoHealth, Inc..

Action: resigned
Role: Director

Exact text from the filing

On September 11, 2022, Ms. Tawil resigned from the Board of the Company as a Centerbridge Director

View on SEC.gov

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-245663

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.